Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai MicroPort Endovascular MedTech Co., Ltd.
  6. Summary
    688016   CNE100003MJ5

SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.

(688016)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
01/14/2022 01/17/2022 01/18/2022 01/19/2022 01/20/2022 Date
234.28 228.47 219.25 218.2 210 Last
1060866 796384 1052546 540467 1010329 Volume
-2.04% -2.48% -4.04% -0.48% -3.76% Change
Estimated financial data (e)
Sales 2021 678 M 107 M 107 M
Net income 2021 302 M 47,7 M 47,7 M
Net cash position 2021 1 169 M 184 M 184 M
P/E ratio 2021 50,0x
Yield 2021 0,58%
Sales 2022 933 M 147 M 147 M
Net income 2022 413 M 65,2 M 65,2 M
Net cash position 2022 1 378 M 217 M 217 M
P/E ratio 2022 36,6x
Yield 2022 0,87%
Capitalization 15 115 M 2 384 M 2 384 M
EV / Sales 2021 20,6x
EV / Sales 2022 14,7x
Nbr of Employees 502
Free-Float 47,1%
More Financials
Company
Shanghai MicroPort Endovascular MedTech Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of aortic and peripheral vascular interventional medical devices. The Company's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral... 
More about the company
Ratings of Shanghai MicroPort Endovascular MedTech Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
2021Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine..
CI
2021Shanghai MicroPort Endovascular MedTech Co., Ltd. Announces Unaudited Financial Results..
CI
2021Shanghai Microport Endovascular Medtech Co., Ltd. Reports Earnings Results for the Half..
CI
2021SHANGHAI MICROPORT ENDOVASCULAR MEDT : Sees Up to 56% Surge in H1 Profit; Shares Tumble 10..
MT
2021Shanghai Microport Endovascular Medtech Co., Ltd. Provides Earnings Guidance for the Si..
CI
2021Shanghai Microport Endovascular Medtech Co., Ltd. Reports Earnings Results for the Firs..
CI
2021Shanghai Microport Endovascular Medtech Co., Ltd. Reports Earnings Results for the Full..
CI
2021Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Ye..
CI
2020SHANGHAI MICROPORT ENDOVASCULAR MEDT : 688016) added to Shanghai Stock Exchange Health Car..
CI
2020Shanghai Hongmai Medical Technology Co., Ltd. announced that it expects to receive fund..
CI
2020Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Unaudited Earnings Results fo..
CI
2020Shanghai Microport Endovascular Medtech Co., Ltd. Announces Earnings Results for the Fi..
CI
2020Certain A Shares of Shanghai MicroPort Endovascular MedTech Co., Ltd. are subject to a ..
CI
2020Shanghai Microport Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Si..
CI
2020Shanghai Lanmai Medical Technology Co., Ltd. announced that it expects to receive CNY 6..
CI
More news
News in other languages on SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
2021Shanghai MicroPort Endovascular enregistre une hausse de 56% de son bénéfice au premier..
2021Shanghai Microport Endovascular Medtech Co., Ltd. fournit des prévisions de résultats p..
2021Shanghai MicroPort Endovascular MedTech Co., Ltd. fournit des prévisions de résultats p..
2020Shanghai Microport Endovascular MedTech Co., Ltd. fournit des prévisions de bénéfices p..
2020Shanghai Microport Endovascular Medtech Co., Ltd. Déclare un dividende en espèces par a..
More news
Chart SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
Duration : Period :
Shanghai MicroPort Endovascular MedTech Co., Ltd. Technical Analysis Chart | 688016 | CNE100003MJ5 | MarketScreener
Technical analysis trends SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 210,00 CNY
Average target price 397,00 CNY
Spread / Average Target 89,0%
EPS Revisions
Managers and Directors
Qing Zhu General Manager & Director
Chun Fang Li Chief Financial Officer
Bo Peng Chairman
Cheng Yun Yue Chairman-Supervisory Board
Hai Bing Wu Independent Director
Sector and Competitors